Drug Target Review2025-11-04T10:54:59
Cambridge-based biotech firm Nuclera has partnered with Solve Scientific Australia to expand access to its eProtein Discovery™ System across Australia and New Zealand.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2023-03-03T14:06:14
Sponsored by Bio-Techne
2026-09-22T07:00:00
Contributor Luca Lotta, Drug Target Review
2026-08-17T14:16:00
Contributor Dr Rab Prinjha, Drug Target Review
2026-08-20T08:43:00
Author Dr Daniel Tillett
2023-07-11T16:13:06
Sponsored by Agilent
2023-05-23T11:10:47
Sponsored by NanoTemper Technologies
Site powered by Webvision Cloud